![Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy | Semantic Scholar Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7f6a812ee1ae1086bcfed087d13c4231caa4fa80/4-Table3-1.png)
Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy | Semantic Scholar
![Preoperative PSA Velocity and the Risk of Death from Prostate Cancer after Radical Prostatectomy | NEJM Preoperative PSA Velocity and the Risk of Death from Prostate Cancer after Radical Prostatectomy | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2004/nejm_2004.351.issue-2/nejmoa032975/production/images/img_medium/nejmoa032975_t2.jpeg)
Preoperative PSA Velocity and the Risk of Death from Prostate Cancer after Radical Prostatectomy | NEJM
![Cancers | Free Full-Text | Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data Cancers | Free Full-Text | Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data](https://www.mdpi.com/cancers/cancers-15-00261/article_deploy/html/images/cancers-15-00261-g001.png)
Cancers | Free Full-Text | Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data
![Cancers | Free Full-Text | PSA and PSA Kinetics Thresholds for the Presence of 68Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer Cancers | Free Full-Text | PSA and PSA Kinetics Thresholds for the Presence of 68Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer](https://www.mdpi.com/cancers/cancers-12-00398/article_deploy/html/images/cancers-12-00398-g001.png)
Cancers | Free Full-Text | PSA and PSA Kinetics Thresholds for the Presence of 68Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer
![Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer | SpringerLink Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00345-019-02664-3/MediaObjects/345_2019_2664_Fig5_HTML.png)
Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer | SpringerLink
![Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL. - Abstract - Europe PMC Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL. - Abstract - Europe PMC](https://europepmc.org/articles/PMC2422995/bin/cuaj1377T2.jpg)
Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL. - Abstract - Europe PMC
![Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system - ScienceDirect Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0731708521005811-ga1.jpg)
Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system - ScienceDirect
Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer | PLOS ONE
![Associations of aspirin, nonsteroidal anti‐inflammatory drug and paracetamol use with PSA‐detected prostate cancer: Findings from a large, population‐based, case–control study (the ProtecT study) - Murad - 2011 - International Journal of Cancer - Associations of aspirin, nonsteroidal anti‐inflammatory drug and paracetamol use with PSA‐detected prostate cancer: Findings from a large, population‐based, case–control study (the ProtecT study) - Murad - 2011 - International Journal of Cancer -](https://onlinelibrary.wiley.com/cms/asset/996705c8-2b61-4e84-a43c-a508f95db426/ntbl003.jpg)
Associations of aspirin, nonsteroidal anti‐inflammatory drug and paracetamol use with PSA‐detected prostate cancer: Findings from a large, population‐based, case–control study (the ProtecT study) - Murad - 2011 - International Journal of Cancer -
![Frontiers | Pathological characteristics and predictive factors of prostate biopsy in patients with serum PSA levels between 0 and 4.0 ng/ml Frontiers | Pathological characteristics and predictive factors of prostate biopsy in patients with serum PSA levels between 0 and 4.0 ng/ml](https://www.frontiersin.org/files/Articles/957892/fonc-12-957892-HTML/image_m/fonc-12-957892-t004.jpg)
Frontiers | Pathological characteristics and predictive factors of prostate biopsy in patients with serum PSA levels between 0 and 4.0 ng/ml
![Correlation Analysis between Working Conditions and the Performance of a Small-Scale Pressure Swing Adsorption Oxygen Production Process | Industrial & Engineering Chemistry Research Correlation Analysis between Working Conditions and the Performance of a Small-Scale Pressure Swing Adsorption Oxygen Production Process | Industrial & Engineering Chemistry Research](https://pubs.acs.org/cms/10.1021/acs.iecr.2c02781/asset/images/medium/ie2c02781_0011.gif)